Jobs / United States / Natera INC
Organ Health Specialist, Transplant
Natera INC · 🇺🇸 North Carolina; Tennessee
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 48 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 12 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Natera INC
The US Department of Labor certified 48 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 12 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Natera INC →
About the role
Territory: North Carolina and Tennessee As an Organ Health Specialist –Thoracic Transplant (Heart and Lung), you will drive sales and adoption of Prospera , a non-invasive blood test for transplant patients. This role focuses on Heart and Lung transplant centers, where the OHS will engage with transplant providers, and key decision-makers to integrate Prospera into clinical practice. • Achieve and exceed sales goals through strategic sales initiatives, relationship-building, and effective territory management. • Drive market adoption of transplant-focused genetic testing solutions by educating and engaging key stakeholders, including transplant specialists, nephrologists, and academic medical centers. • Leverage industry expertise to establish credibility and effectively position genetic testing solutions within the transplant ecosystem. • Develop and execute tailored business plans that align with sales objectives, optimize resources, and address unique market dynamics in transplant and specialty medicine. • Cultivate and maintain relationships with key opinion leaders (KOLs) in transplant and related specialties to enhance brand visibility and market influence. • Navigate complex sales environments with a proactive, problem-solving mindset, demonstrating initiative, urgency, and adaptability in a dynamic, fast-paced setting. • Represent the company with professionalism and technical expertise, staying up to date on advancements in genetic testing, laboratory diagnostics, and the transplant landscape. • Work independently while collaborating cross-functionally to drive business growth and contribute to a high-performance sales culture. Qualifications: • Bachelor’s degree or equivalent experience required. • Minimum of 6 years of progressive sales experience, ideally in lab-developed tests, diagnostics, or transplant-related specialties. • Deep understanding of transplant settings or similar specialty medicine. • Existing relationships with KOLs in transplant or similar fields preferred. • Proven track record of closing deals, driving growth, and building strong client relationships. • Experience launching new products and building a brand in the transplant market. • Comfortable in a startup-like setting with strong initiative, self-motivation, and time management skills. • Strong problem-solving abilities with a creative, independent approach to overcoming challenges. • Excellent communication, presentation, and interpersonal skills. Work Environment & Travel: • Remote role with field-based responsibilities requiring 3-4 days of travel per week. • Must be able to work flexible hours, including occasional evenings and weekends. • Position requires frequent use of a computer, phone, and digital communication tools to interact with clients and internal teams. The total On Target Earnings (OTE) offers a competitive base salary and uncapped quarterly commissions. In addition we also offer a car allowance, and Restricted Stock Units (RSUs). The compensation package listed is for 1st year OTE, which are based on a wide array of factors unique to each candidate, including but not limited to skill set, years & depth of experience, certifications and specific office location. On-target earnings (OTE) represent the total potential income an employee can earn by achieving 100% of their performance goals. It combines a base salary with commissions and serves as an estimated figure rather than a guaranteed amount, providing a guideline based on average performance outcomes. On-target earnings (OTE) $185,000 — $215,000 USD OUR OPPORTUNITY Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics